You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)夥控股股東設合營 拓遙距診斷解決方案
阿思達克 06-01 09:56
復星醫藥(02196.HK)公布,附屬禪城醫院與公司控股股東郭廣昌持有的杏脈科技,就設立合資公司訂立合同,合資公司註冊資本為500萬元人民幣(下同),其中禪城醫院及杏脈科技擬分別以現金出資250萬元,各佔合資公司50%的股權,合資公司將成為公司合營企業。

公司表示,設立合資公司旨在順應國家分級診療制度推進,借助禪城醫院及杏脈科技各自現有的醫療及數智能力優勢,為各類醫療機構提供包括「遠程影像、即時診斷」功能在內的各項解決方案。設立合資公司亦有助於推動公司醫療服務數字化及智能化水平以及質量的持續提升。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account